2/28/23 18:28  | 2/25/23  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 9 | 48 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/23 18:28  | 2/27/23  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.68 | 0 | -2 | -4 | 48 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/22 17:25  | 11/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/22 17:25  | 11/28/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -6 | 2.72 | 0 | -2 | -4 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/29/22 21:18  | 8/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 10 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/29/22 21:18  | 8/26/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -9 | 4.01 | 0 | -2 | -5 | 44 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/27/22 17:32  | 5/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/27/22 17:32  | 5/26/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -4 | 1.90 | 0 | -2 | -5 | 42 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/22 21:12  | 2/25/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 4 | 11 | 40 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/1/22 21:12  | 2/28/22  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.d | -7 | 2.78 | 0 | -2 | -6 | 40 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/21 19:50  | 11/25/21  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 0 | 0.00 | 0 | 8 | 27 | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/29/21 19:50  | 11/26/21  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | S.dm | -22 | 4.81 | 0 | -5 | -11 | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/13/21 17:46  | 5/11/21  | VIRX | Viracta Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Rojkjaer Lisa | CA | O | Chief Me | M.d | 49 | 1.40 | 0 | 35 | New | 35 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |